Literature DB >> 21184614

Immediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxides.

Yan Zhong1, Steven G Carmella, Pramod Upadhyaya, J Bradley Hochalter, Diane Rauch, Andrew Oliver, Joni Jensen, Dorothy Hatsukami, Jing Wang, Cheryl Zimmerman, Stephen S Hecht.   

Abstract

Polycyclic aromatic hydrocarbons (PAH) are among the likely major causative agents for lung cancer in smokers. PAH require metabolic activation to exert their carcinogenic effects, and one important pathway proceeds through a three-step sequence resulting in the formation of diol epoxides, which react with DNA to produce adducts that can cause mutations and initiate the carcinogenic process. However, no previous published studies have examined this critical pathway in humans specifically exposed to PAH by inhalation of cigarette smoke. This study used a unique approach employing a stable isotope derivative of phenanthrene, the simplest PAH with a bay region, a feature closely associated with PAH carcinogenicity. Twelve subjects each smoked a cigarette to which [D(10)]phenanthrene had been added. Plasma was analyzed for [D(10)]r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene ([D(10)]PheT), the major end product of the diol epoxide metabolism pathway of phenanthrene. The analysis was performed by gas chromatography--negative ion chemical ionization--tandem mass spectrometry, using [(13)C(6)]PheT as internal standard. The results demonstrated that the three-step pathway resulting in the formation of diol epoxides, as monitored by [D(10)]PheT, occurred with remarkable rapidity. Levels of [D(10)]PheT in plasma of all subjects were maximal at the earliest time points examined, 15-30 min after smoking the cigarette containing [D(10)]phenanthrene, and decreased thereafter. These results demonstrate that the formation of a PAH diol epoxide occurs rapidly in smokers. Because PAH diol epoxides are mutagenic and carcinogenic, the results clearly demonstrate immediate negative health consequences of smoking, which should serve as a major warning to anyone contemplating initiating tobacco use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184614      PMCID: PMC3042042          DOI: 10.1021/tx100345x

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  26 in total

1.  Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.

Authors:  Delia Dempsey; Piotr Tutka; Peyton Jacob; Faith Allen; Kerri Schoedel; Rachel F Tyndale; Neal L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2004-07       Impact factor: 6.875

2.  Preferential glutathione conjugation of a reverse diol epoxide compared with a bay region diol epoxide of benzo[a]pyrene in human hepatocytes.

Authors:  Pramod Upadhyaya; J Bradley Hochalter; Silvia Balbo; Edward J McIntee; Stephen S Hecht
Journal:  Drug Metab Dispos       Date:  2010-06-14       Impact factor: 3.922

3.  Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes.

Authors:  M Nordqvist; D R Thakker; K P Vyas; H Yagi; W Levin; D E Ryan; P E Thomas; A H Conney; D M Jerina
Journal:  Mol Pharmacol       Date:  1981-01       Impact factor: 4.436

Review 4.  Biomonitoring of polycyclic aromatic hydrocarbons in human urine.

Authors:  Jürgen Jacob; Albrecht Seidel
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-10-05       Impact factor: 3.205

Review 5.  Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.

Authors:  Gerd P Pfeifer; Mikhail F Denissenko; Magali Olivier; Natalia Tretyakova; Stephen S Hecht; Pierre Hainaut
Journal:  Oncogene       Date:  2002-10-21       Impact factor: 9.867

Review 6.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer.

Authors:  Stephen S Hecht
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

Review 7.  Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods.

Authors:  Gunnar Boysen; Stephen S Hecht
Journal:  Mutat Res       Date:  2003-01       Impact factor: 2.433

Review 8.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer.

Authors:  Stephen S Hecht
Journal:  Carcinogenesis       Date:  2002-06       Impact factor: 4.944

9.  r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation.

Authors:  Stephen S Hecht; Menglan Chen; Haruhiko Yagi; Donald M Jerina; Steven G Carmella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-12       Impact factor: 4.254

Review 10.  Smoking-related DNA and protein adducts in human tissues.

Authors:  David H Phillips
Journal:  Carcinogenesis       Date:  2002-12       Impact factor: 4.944

View more
  22 in total

1.  Excretion profiles and half-lives of ten urinary polycyclic aromatic hydrocarbon metabolites after dietary exposure.

Authors:  Zheng Li; Lovisa Romanoff; Scott Bartell; Erin N Pittman; Debra A Trinidad; Michael McClean; Thomas F Webster; Andreas Sjödin
Journal:  Chem Res Toxicol       Date:  2012-06-13       Impact factor: 3.739

2.  Metabolism of [D10]phenanthrene to tetraols in smokers for potential lung cancer susceptibility assessment: comparison of oral and inhalation routes of administration.

Authors:  Yan Zhong; Jing Wang; Steven G Carmella; J Bradley Hochalter; Diane Rauch; Andrew Oliver; Joni Jensen; Dorothy K Hatsukami; Pramod Upadhyaya; Cheryl Zimmerman; Stephen S Hecht
Journal:  J Pharmacol Exp Ther       Date:  2011-04-22       Impact factor: 4.030

3.  Benzo[ a]pyrene Induction of Glutathione S-Transferases: An Activity-Based Protein Profiling Investigation.

Authors:  Ethan G Stoddard; Bryan J Killinger; Subhasree A Nag; Jude Martin; Richard Corley; Jordan N Smith; Aaron T Wright
Journal:  Chem Res Toxicol       Date:  2019-04-12       Impact factor: 3.739

4.  Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop.

Authors:  Cindy M Chang; Selvin H Edwards; Aarthi Arab; Arseima Y Del Valle-Pinero; Ling Yang; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-11-09       Impact factor: 4.254

Review 5.  Biomarkers of exposure to new and emerging tobacco delivery products.

Authors:  Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

Review 6.  Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer.

Authors:  Shanbeh Zienolddiny; Vidar Skaug
Journal:  Lung Cancer (Auckl)       Date:  2011-12-29

7.  Automated 3-D Printed Arrays to Evaluate Genotoxic Chemistry: E-Cigarettes and Water Samples.

Authors:  Karteek Kadimisetty; Spundana Malla; James F Rusling
Journal:  ACS Sens       Date:  2017-05-02       Impact factor: 7.711

8.  Longitudinal study of [D10]phenanthrene metabolism by the diol epoxide pathway in smokers.

Authors:  Stephen S Hecht; J Bradley Hochalter; Steven G Carmella; Yan Zhang; Diane M Rauch; Naomi Fujioka; Joni Jensen; Dorothy K Hatsukami
Journal:  Biomarkers       Date:  2013-01-22       Impact factor: 2.658

9.  Paper-based electrochemiluminescent screening for genotoxic activity in the environment.

Authors:  Vigneshwaran Mani; Karteek Kadimisetty; Spundana Malla; Amit A Joshi; James F Rusling
Journal:  Environ Sci Technol       Date:  2013-02-01       Impact factor: 9.028

10.  Quantitation of enantiomers of r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]-pyrene in human urine: evidence supporting metabolic activation of benzo[a]pyrene via the bay region diol epoxide.

Authors:  Stephen S Hecht; Jon Bradley Hochalter
Journal:  Mutagenesis       Date:  2014-07-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.